PANK2

Chr 20AR

pantothenate kinase 2

Also known as: C20orf48, HARP, HSS, NBIA1, PKAN

This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.971 OMIM phenotype
Clinical SummaryPANK2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
147 unique Pathogenic / Likely Pathogenic· 245 VUS of 813 total submissions
📖
GeneReview available — PANK2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.97LOEUF
pLI 0.000
Z-score 1.68
OE 0.61 (0.400.97)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.18Z-score
OE missense 0.97 (0.881.07)
298 obs / 306.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.61 (0.400.97)
00.351.4
Missense OE?0.97 (0.881.07)
00.61.4
Synonymous OE?1.26
01.21.6
LoF obs/exp: 13 / 21.4Missense obs/exp: 298 / 306.8Syn Z: -2.36
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePANK2-related HARP syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6744th %ile
GOF
0.5071th %ile
LOF
0.4431th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

813 submitted variants in ClinVar

Classification Summary

Pathogenic84
Likely Pathogenic63
VUS245
Likely Benign330
Benign28
Conflicting49
84
Pathogenic
63
Likely Pathogenic
245
VUS
330
Likely Benign
28
Benign
49
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
56
18
10
0
84
Likely Pathogenic
26
35
2
0
63
VUS
7
222
14
2
245
Likely Benign
0
10
98
222
330
Benign
0
1
26
1
28
Conflicting
49
Total89286150225799

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

33 pathogenic / likely-pathogenic (of 51) ClinVar copy-number / structural variants overlap PANK2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PANK2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →